trans-[4'-Butyl-1,1'-bicyclohexyl]-4-one, 95%, 500g

(2S,4S)-4-(tert-butoxy)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid, 95.0%, 50mg

2-Methylhexanoic Acid>98.0%(GC)(T)25mL

9-Methoxy-1,2,3,4-tetrahydropyrazino[1,2-a]indole, 97%, 100mg

1,6,10-Dodecatriene, 7,11-dimethyl-3-methylene-, (6E)-, 95%, 1g

(2-Fluoro-5-(trifluoromethyl)phenyl)hydrazine hydrochloride, 96%, 250mg

3-Ethynyl-imidazo[1,2-a]pyrazine, 97%, 250mg

1-Benzyl-3,3-dimethylpiperidin-4-amine, 95.0%, 10g

9-Ethyl-9H-carbazole, 95.0%, 500g

Tert-butyl (3S,4S)-3-(hydroxymethyl)-4-methylpyrrolidine-1-carboxylate, 98+%, 100mg

3-methyl-1-(3-nitrobenzoyl)piperazine, 95.0%, 1g

2-(3-METHOXY-2-METHYLPHENYL)ACETIC ACID, 95.0%, 250mg

(1-(4-(Trifluoromethyl)phenyl)cyclopropyl)methanol, 98%, 1g